LOGIN
Titrated THC and CBD does not significantly improve spasticity compared to placebo over 4 weeks
January 2019
Titrated THC and CBD does not significantly improve spasticity compared to placebo over 4 weeks
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Sativex and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis
J Neurol. 2015 Nov;262(11):2520-7Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
34 patients with progressive multiple sclerosis were treated with titrated doses of Sativex (9-delta-tetrahydrocannabinol and cannabidiol oromucosal spray) or placebo in a randomly assigned order for 4 weeks each. The purpose of the study was to determine if of 9-delta-tetrahydrocannabinol and cannabidiol treatment significantly improves neurophysiological and clinical measures of spasticity, pain...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.